false0000927653
0000927653
2020-03-17
2020-03-17
0000927653
mck:A3.125NotesDue2029Member
2020-03-17
2020-03-17
0000927653
mck:A0.625notesDue2021Member
2020-03-17
2020-03-17
0000927653
mck:A1.625NotesDue2026Member
2020-03-17
2020-03-17
0000927653
mck:A1.500NotesDue2025Member
2020-03-17
2020-03-17
0000927653
us-gaap:CommonStockMember
2020-03-17
2020-03-17
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
Date of report (Date of earliest event reported): March 17, 2020
McKESSON CORPORATION
(Exact Name of Registrant as Specified in Charter)
|
| | | | |
| | | | |
Delaware | | 1-13252 | | 94-3207296 |
(State or Other Jurisdiction of Incorporation) | | (Commission File Number) | | (I.R.S. Employer Identification No.) |
6555 State Hwy 161
Irving, TX 75039
(Address of Principal Executive Offices, and Zip Code)
(972) 446-4800
Registrant’s Telephone Number, Including Area Code
Not Applicable
(Former Name or Former Address, if Changed Since Last Report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
|
| |
☐ | Written communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
☐ | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
☐ | Pre-commencement communication pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
☐ | Pre-commencement communication pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Securities registered pursuant to Section 12(b) of the Act:
|
| | | | |
Title of each class | | Trading Symbol(s) | | Name of each exchange on which registered |
Common stock, $0.01 par value | | MCK | | New York Stock Exchange |
0.625% Notes due 2021 | | MCK21A | | New York Stock Exchange |
1.500% Notes due 2025 | | MCK25 | | New York Stock Exchange |
1.625% Notes due 2026 | | MCK26 | | New York Stock Exchange |
3.125% Notes due 2029 | | MCK29 | | New York Stock Exchange |
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 7.01 Regulation FD Disclosure
On March 17, 2020, the Company issued and posted on its website a press release regarding a previously-announced investor call on March 17, 2020 to discuss the Company's completion of the exit of its investment in Change Healthcare LLC. In that press release, the Company also provided an updated forecast of its Adjusted Earnings per diluted share for full-year fiscal 2020. A copy of that press release is attached as Exhibit 99.1.
The information contained in this item, including Exhibit 99.1, is furnished to the Commission, but shall not be deemed “filed” with the Commission for purposes of Section 18 of the Securities Exchange Act of 1934 (“Exchange Act”), or incorporated by reference in any filing under the Exchange Act or the Securities Act of 1933, except as expressly stated in any such filing.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits.
|
| | | |
| | |
Exhibit No. | | Description |
| |
99.1 |
| | |
104 |
| | Cover Page Interactive Data File - the cover page iXBRL tags are embedded within the Inline XBRL document |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Date: March 17, 2020
|
| | |
| | |
McKesson Corporation |
| |
| By: | /s/ Britt J. Vitalone |
| | Britt J. Vitalone |
| | Executive Vice President and |
| | Chief Financial Officer |